Search
-
Insurance resources specifically for cancer survivors
… People who have had cancer can still qualify for life insurance; however, it will likely be more difficult. Acquiring coverage often depends on the specific insurance company, each of which has different requirements based on the type of cancer you had or how long you have been out of treatment. Some
-
Patient & Caregiver Education
This information explains what to expect after you complete your prostate radiation.
… This information explains what to expect after you complete your prostate radiation. Follow-up Appointments After you finish your radiation therapy, you will have follow-up appointments. Your visits will be with your doctor or advanced practice provider (APP). An APP is a healthcare provider with special
-
Patient & Caregiver Education
En esta información se explica qué esperar después de terminar su radioterapia de próstata.
… En esta información se explica qué esperar después de terminar su radioterapia de próstata. Citas de seguimiento Una vez que termine su radioterapia, tendrá citas de seguimiento. Su médico de cabecera o su proveedor de práctica avanzada (APP) le atenderán en estas visitas. Un APP es un proveedor de cuidados
-
Patient & Caregiver Education
Эта информация поможет вам узнать, чего ожидать после прохождения курса радиотерапии предстательной железы.
… Эта информация поможет вам узнать, чего ожидать после прохождения курса радиотерапии предстательной железы. Последующее наблюдение После окончания курса радиотерапии вам назначат приемы с целью последующего наблюдения. Вы будете посещать врача или квалифицированного медработника (advanced practice provider
-
The Derek Tan Lab
Christopher Gerry studies organic chemistry and chemical biology in the Tan laboratory at MSKCC.
… Job Title Summer Intern Graduate Student, 2014–present with Prof. Stuart L. Schreiber Department of Chemistry & Chemical Biology Harvard University BS, Amherst College, 2014 Rubin and Sarah Shaps Scholar, 2012 Summer Undergraduate Research Intern, 2012 Gerstner Sloan Kettering Graduate School Publications
-
The Alexandros Pertsinidis Lab
… Tea will be served at 11:45 a.m. , immediately preceding the seminar. Audience This seminar is open to the research community. Location Memorial Sloan Kettering Cancer Center Zuckerman Research Center 417 East 68th Street Room ZRC-105 New York, NY 10065 Speaker(s) Taekjip (TJ) Ha, PhD Professor Department
-
Advancements in cervical cancer treatment mean the outlook for women with this disease have never been better. Find out how MSK experts are improving outcomes and quality of life for women with cervical cancer.
… The outlook for women with cervical cancer has never been better. And our doctors and specialists are always looking for new ways to improve the treatment options for women with this disease. Each year, approximately 200 women with cervical cancer, and 50 with invasive disease, come to us for care. And
-
-
Technology Development
… Species: Human Category: Cancer Tissue of Origin: Rectal Tumor Cancer Type: Melanoma Description SK-MEL-37 is a human melanoma cell line. Source This cell line was established from a metastatic lymph node in a 65-year-old male with malignant melanoma. Lead Researcher/Research Laboratory Lloyd J.
-